Sector
PharmaceuticalsOpen
₹65.4Prev. Close
₹64.75Turnover(Lac.)
₹88.89Day's High
₹67.98Day's Low
₹61.5152 Week's High
₹74.852 Week's Low
₹31.35Book Value
₹47Face Value
₹10Mkt Cap (₹ Cr.)
191.85P/E
47.5EPS
1.42Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 32.99 | 30.02 | 27.7 | 25.7 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 99.79 | 87.39 | 85.94 | 73.16 |
Net Worth | 132.78 | 117.41 | 113.64 | 98.86 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 348.41 | 300.08 | 349.34 | 395.96 |
yoy growth (%) | 16.1 | -14.1 | -11.77 | 60.94 |
Raw materials | -337.79 | -290.18 | -337.36 | -382.98 |
As % of sales | 96.95 | 96.69 | 96.56 | 96.72 |
Employee costs | -0.39 | -0.39 | -0.38 | -0.33 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 8.3 | 7.24 | 8.19 | 7.97 |
Depreciation | -0.92 | -0.89 | -0.71 | -0.64 |
Tax paid | -1.78 | -1.44 | -2.01 | -2.5 |
Working capital | 6.66 | 26.65 | 23.78 | 5.56 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.1 | -14.1 | -11.77 | 60.94 |
Op profit growth | 43.51 | -57.69 | -20.51 | 848.64 |
EBIT growth | 18.89 | -10.71 | -17.84 | 248.55 |
Net profit growth | 12.44 | -6.21 | 12.85 | 324.54 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Mihir R Ghatalia
Independent Director
Chetan K Mehta
Independent Director
Lalit Tulsiani
Executive Director
Nimit R Ghatalia
Independent Director
Anil Mandal
Non Executive Director
Bina Ghatalia
Company Sec. & Compli. Officer
KAILASH CHAND JETHLIA
E-34 MIDC Tarapur,
Boisar,
Maharashtra - 401506
Tel: 91-22-23455543
Website: http://www.aareydrugs.com
Email: [email protected]
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: [email protected]
Summary
Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally pro...
Read More
Reports by Aarey Drugs & Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.